An Open-Label, Single-Arm Clinical Study to evaluate the Safety and Tolerability of HHIC-102107 Capsules in Healthy Adults

Himalaya Wellness Company0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年4月3日

试验速览

暂无简介。

•1.Healthy adult subjects of either sex aged between >= 18 to <= 50 years.
•2.Subjects willing to sign informed consent and follow the study procedure.
•3.Has not participated in a similar investigation in the past four weeks.
•4.Subjects willing to refrain taking any other similar supplements during the study period.

•1.Subjects with clinically significant serious cardiovascular, cerebrovascular, respiratory, hepatic, renal disease, congenital or any other disorder.
•2.Subject with abnormal lab values detected at the time of screening shall be excluded.
•3.A known history or present condition of allergic response to pharmaceutical products its components or ingredients in the investigational product.
•4.Pre-existing systemic disease necessitating long-term medications.
•5.Genetic and endocrinal disorders.
•6.Subjects who refused to sign informed consent.
•7.Pregnant and lactating women.

发起方